Atala Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$633K Buy
547
+10
+2% +$11.8K 0.37% 64
2026
Q2
$644K Buy
537
+4
+0.8% +$4.09K 0.39% 63
2026
Q1
$498K Buy
533
+9
+2% +$9.12K 0.33% 69
2025
Q4
$563K Hold
524
– – 0.36% 61
2025
Q3
$400K Sell
524
-221
-30% -$164K 0.25% 76
2025
Q2
$581K Hold
745
– – 0.4% 59
2025
Q1
$615K Hold
745
– – 0.45% 56
2024
Q4
$575K Buy
+745
New +$617K 0.4% 58

Other funds holding LLY

Atala Financial's LLY Position: Q3 2026 in Review

Atala Financial increased its Eli Lilly (LLY) stake by 1.9% in Q3 2026, buying an estimated $11.8K and bringing the position to 547 shares worth $633K. The position accounts for 0.37% of the portfolio, ranked #64.

Atala Financial first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $644K in Q2 2026. 1,509 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Atala Financial held 547 shares of Eli Lilly worth $633K as of Q3 2026.
  • Atala Financial bought 10 Eli Lilly shares in Q3 2026, an estimated $11.8K.
  • Eli Lilly made up 0.37% of Atala Financial's portfolio in Q3 2026, its #64 holding.
  • Atala Financial first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • Atala Financial's Eli Lilly position peaked at $644K in Q2 2026.
  • 1,509 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Atala Financial's 13F filing for Q3 2026, filed 22 Oct 2026.